<?xml version="1.0" encoding="UTF-8"?>
<p id="p0310">Over the past decades, efforts have been done by the pharmaceutical industry to the development, evaluation, and implementation of in vitro alternatives to animal testing in the hazard identification and risk assessment of preclinical drug candidates (
 <xref rid="bib25" ref-type="bibr">Goh et al., 2015</xref>).
</p>
